ESMO Breast Cancer 2023 Congress Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ESMO Breast Cancer 2023 Congress Coverage

Videos

Playback speed

10 seconds

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analysis: T-DXd vs. TPC in HER2-Low Unresectable and/or Metastatic BC

By ESMO Breast Cancer 2023 Congress Coverage FEATURING Hope Rugo

51 views

May 25, 2023

Comments 0

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Videos

ESMO Breast Cancer 2023 Clinical Impact of Evolving ADC Technology

ESMO Breast Cancer 2023 Congress Coverage

H. McArthur

161 views

ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window o…

ESMO Breast Cancer 2023 Congress Coverage

M. Oliveira

307 views

ESMO Breast Cancer 2023: Role of Germline Genetic Testing in Early B…

ESMO Breast Cancer 2023 Congress Coverage

S. Lee

122 views

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

868 views

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analys…

ESMO Breast Cancer 2023 Congress Coverage

H. Rugo

51 views

ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clini…

ESMO Breast Cancer 2023 Congress Coverage

K. Gelmon

106 views

ESMO Breast Cancer 2023 Clinical Implementation of Oral SERD: Presen…

ESMO Breast Cancer 2023 Congress Coverage

C. Criscitiello

263 views

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib …

ESMO Breast Cancer 2023 Congress Coverage

T. Tan

51 views

ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…

ESMO Breast Cancer 2023 Congress Coverage

P. Tarantino

768 views

ESMO Breast Cancer 2023: Who Really Benefits From IO? Can We Identif…

ESMO Breast Cancer 2023 Congress Coverage

J. Balko

45 views

ESMO Breast Cancer 2023 EMERALD Trial: Analysis of PROs in Patients …

ESMO Breast Cancer 2023 Congress Coverage

J. Cortes

502 views

ESMO Breast Cancer 2023 DATA Trial Analysis: The Prognostic and Pred…

ESMO Breast Cancer 2023 Congress Coverage

S. Lammers

54 views